BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28060113)

  • 21. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
    Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Raney RB; Walterhouse DO; Meza JL; Andrassy RJ; Breneman JC; Crist WM; Maurer HM; Meyer WH; Parham DM; Anderson JR
    J Clin Oncol; 2011 Apr; 29(10):1312-8. PubMed ID: 21357783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.
    Boutroux H; Cellier C; Mosseri V; Helfre S; Levy C; Desjardins L; Plancher C; Freneaux P; Michon J; Orbach D
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):605-12. PubMed ID: 25171453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
    Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
    Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
    J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdomyosarcoma of the head and neck in children: review and update.
    Reilly BK; Kim A; Peña MT; Dong TA; Rossi C; Murnick JG; Choi SS
    Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1477-83. PubMed ID: 26231745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
    Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
    J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
    Weigel BJ; Breitfeld PP; Hawkins D; Crist WM; Baker KS
    J Pediatr Hematol Oncol; 2001; 23(5):272-6. PubMed ID: 11464981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.
    Walterhouse DO; Pappo AS; Baker KS; Parham DM; Anderson JR; Donaldson SS; Paidas CN; Womer RB; Crist WM
    Cancer; 2001 Dec; 92(12):3135-46. PubMed ID: 11753993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
    Kojima Y; Hashimoto K; Ando M; Yonemori K; Yamamoto H; Kodaira M; Yunokawa M; Shimizu C; Tamura K; Hosono A; Makimoto A; Fujiwara Y
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):391-7. PubMed ID: 22806306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
    J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
    Casey DL; Wexler LH; Wolden SL
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
    Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdomyosarcoma of the head and neck in children.
    Coene IJ; Schouwenburg PF; Voûte PA; Marion J; Burgers V; Hilgers FJ
    Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):291-6. PubMed ID: 1382002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
    Bergamaschi L; Bertulli R; Casanova M; Provenzano S; Chiaravalli S; Gasparini P; Collini P; Sangalli C; Gandola L; Diletto B; Morosi C; Fiore M; Massimino M; Ferrari A
    Med Oncol; 2019 May; 36(7):59. PubMed ID: 31104202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary elaboration of the method of complex treatment of rhabdomyosarcoma].
    Bozek J; Czerwiński W; Woźniak W
    Probl Med Wieku Rozwoj; 1984; 13():154-63. PubMed ID: 6549411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results.
    Flamant F; Rodary C; Voute PA; Otten J
    Radiother Oncol; 1985 Apr; 3(3):227-36. PubMed ID: 3890032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of pediatric patients with newly diagnosed rhabdomyosarcoma treated by two consecutive protocols - A single institution report in Taiwan.
    Chou SW; Chang HH; Lu MY; Yang YL; Lin DT; Lin KH; Jou ST
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):332-340. PubMed ID: 29903549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.